Three days in Basel concentrate advances in antibody engineering and ADCs. Antibody Engineering & Therapeutics Europe 2027 takes place 1 to 3 June 2027 at the Congress Center Basel and gathers researchers and solution providers from the biopharma ecosystem.
Practical information for Antibody Engineering & Therapeutics Europe 2027
The event runs from 1 to 3 June 2027 at the Congress Center in Basel. The organizer provides both on-site and digital passes and a hotel map on the official site. Bring concise technical materials that allow you to present capabilities in under five minutes to make the most of short meetings.
Sectors and company profiles at Antibody Engineering & Therapeutics Europe 2027
The event targets biotechnology and pharmaceutical companies focused on antibody discovery and therapeutic development. Attendees include academic groups, discovery teams from biopharma, platform providers for protein engineering and vendors of conjugation and payload technologies. The mix spans preclinical research and partners for scale up and analytics.
Program highlights for Antibody Engineering & Therapeutics Europe 2027
The scientific program features tracks on ADCs and bioconjugates along with sessions on discovery and engineering of antibodies. Key themes cover emerging in vitro and in vivo discovery approaches, Fc region modulation, multispecific formats, cell engagers and conditionally activated antibodies. The agenda also includes poster sessions and an exhibit hall showcasing platform providers.
Key figures for Antibody Engineering & Therapeutics Europe 2027
- Three days of programming from 1 to 3 June 2027
- Venue Congress Center Basel
- 250 attendees reported for the event
- More than 80 expert speakers across antibody science
- Over 20 sponsors and more than 30 exhibition partners
- Numerous posters presenting recent antibody research
Commercial prospecting and networking at Antibody Engineering & Therapeutics Europe 2027
Pre event planning
- Identify your top 10 target organizations on the attendee list and request meetings early using the ConnectMe app or the registration platform.
- Prepare a one page technical brief with concrete use cases and performance metrics to maximize short meeting time.
Messaging and demos
- Highlight measurable improvements your solution brings to discovery or ADC development. Provide throughput, timeline reductions or analytical gains when available.
- For experimental technologies, prepare brief reproducible demos that evaluate suitability in 10 to 15 minutes.
Follow up
- Send a personalized recap within 24 to 48 hours with a clear next step and links to technical assets hosted online to avoid heavy attachments.
Closing note and official link
If your work sits at the intersection of antibody discovery, protein engineering or ADC development, use the concentrated program to validate suppliers and refresh your technology roadmap. Book meetings and consult the full program at the official site https://informaconnect.com/antibody-engineering-europe/ before attending.
